-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Mitsubishi Chemical Methacrylates Corporation (MCM) and partner Agilyx Corporation, a wholly owned subsidiary of Agilyx, announced the success of a full-scale production trial of PMMA depolymerization at Agilyx's Tigard, Oregon facility
.
The results of the full-scale trial conducted in August 2021 were consistent with the successful results of the laboratory-scale trial conducted in 2020
.
The raw materials were mixed including cast and extruded PMMA sheets, and the effect of different temperature settings was analyzed to find the optimal conditions for PMMA pyrolysis
.
Following a successful factory trial, experts from MCM and Agilyx met to develop an action plan outlining the next steps required
.
David Smith, Head of Circular Economy Programs at MCM, said: “The results from full-scale production are very encouraging
.
The teams at MCM and Agilyx have worked very well together and all parties are excited about the prospect of building a new PMMA depolymerization plant using Agilyx technology
.
”
“The results of our PMMA trials at Tigard have been very positive,” said Carsten Larsen, Agilyx Chief Financial Officer.
“We have demonstrated that Agilyx technology can convert PMMA into its original monomeric MMA, creating a truly cyclic material
.
We are delighted Continue to work with MCM
.
"
Crude MMA produced during plant trials is currently being distilled at MCM's pilot plant in Wilton, UK, and will be used for in-house product development and validation
.